1. A hypothesis on the pathophysiological mechanisms that underlie levodopa or dopamine agonist-induced dyskinesia in Parkinson's disease. Implications for future strategies in treatment;Crossman, A.R.;Mov Disord,1990
2. GABA and GABAergic medication relating to striatal dopamine function and Parkinsonism;Bartholini, G.; Uloyd, K.G.; Worms, I.; Constantinides, J.; Tisset, R.;Adv Neurol,1979
3. Potentiation of the L-dopa effect in Parkinsonism by a direct GABA receptor agonist;Lancet,1984
4. Clinical and biochemical effects of gamma-vinyl gaba in tardive dyskinesia;Gaio, J.M.; Pollak, P.; Hommel, M.;J Neurol Neurosurg Psychiatry,1987
5. Shintomi Y Two cases of congenital Horner's syndrome;Hyodo, T.; Kare, M.;Folia Ophthalmol,1983